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Abstract We designed a pilot study of a training module for nurses to perform rheumatic heart disease
echocardiography screening in a resource-poor setting. The aim was to determine whether nurses given brief,
focused, basic training in echocardiography could follow an algorithm to potentially identify cases of
rheumatic heart disease requiring clinical referral, by undertaking basic two-dimensional and colour Doppler
scans. Training consisted of a week-long workshop, followed by 2 weeks of supervised field experience. The
nurses’ skills were tested on a blinded cohort of 50 children, and the results were compared for sensitivity and
specificity against echocardiography undertaken by an expert, using standardised echocardiography definitions
for definite and probable rheumatic heart disease. Analysis of the two nurses’ results revealed that when a
mitral regurgitant jet length of 1.5 cm was used as the trigger for rheumatic heart disease identification, they
had a sensitivity of 100% and 83%, respectively, and a specificity of 67.4% and 79%, respectively. This pilot
supports the principle that nurses, given brief focused training and supervised field experience, can follow an
algorithm to undertake rheumatic heart disease echocardiography in a developing country setting to facilitate
clinical referral with reasonable accuracy. These results warrant further research, with a view to developing a
module to guide rheumatic heart disease echocardiographic screening by nurses within the existing public
health infrastructure in high-prevalence, resource-poor regions.
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I
DENTIFYING A FEASIBLE AND APPROPRIATE MODEL FOR
conducting rheumatic heart disease screening as
part of a public health programme in resource-
poor areas is a challenge for health ministries in
developing countries. Undertaking routine screen-
ing to detect cases early in their disease process is
recommended, but difficult when the populations
are located remotely from major centres, with
limited resources and a lack of available skilled
staff. In industrialised countries, echocardiographers
undertake complex echocardiography scanning in
hospitals on patients with complex cardiac condi-
tions; however, echocardiographers are a scarce
resource in developing countries.
A recent screening study in Fiji found a
prevalence of clinical rheumatic heart disease, that
is, with a significant cardiac murmur, of 8.4 per
1000 in children aged 5–14 years.1 Additional field
studies undertaken in 2008 in Fiji demonstrated
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that the approach of using auscultation to detect
suspicious heart murmurs, followed up with con-
firmatory echocardiography, lacked sensitivity and
missed the majority of rheumatic heart disease cases
detected if all children underwent echocardiography
examination.2 This supports findings of similar
rheumatic heart disease echocardiography studies
undertaken in Nicaragua, Tonga, New Zealand, India,
Cambodia, and Mozambique.3–7 Taken together, this
evidence suggests that potentially up to 10 times as
many cases of rheumatic heart disease are detected
using echocardiography compared with auscultation;
however, the meaning of subtle findings on echo-
cardiography is yet to be completely elucidated in
follow-up studies. If this were the case, there would be
many cases of undiagnosed rheumatic heart disease
in schoolchildren in Fiji. One challenge to finding
these children is to devise a screening protocol that is
practical and affordable in a country like Fiji. In
wealthy, well-resourced countries, it is not uncommon
for nurses to be involved in ultrasonographic or
echocardiographic procedures; however, these nurses
have generally had many years of hands-on supervised
training or completed lengthy postgraduate courses at
tertiary institutions. A search of the recent literature
indicates that this is the first study of its kind in a
resource-poor setting.
We therefore designed a pilot study of a training
module for nurses to determine whether they could
perform rheumatic heart disease echocardiography at
the level of undertaking basic two-dimensional and
colour echocardiography scans. The pilot training
was developed with the following guiding principles:
the nurses would be trained only in basic rheumatic
heart disease screening echocardiography, that is, it
was not our intention to train them to a level of a
formally qualified echocardiographer; they would
receive weeks to months of training rather than years,
and the model would be such that it could be
reproduced in other similar settings using available
local capacity. The aim of the model was for nurse
echocardiographers to identify a relatively small
subset of children with possibly abnormal findings,
who would then be referred for confirmatory
echocardiography by a more highly trained echocar-
diographer. This model requires high sensitivity and
relatively high specificity, to minimise the number of
missed cases while not requiring too many children
to have confirmatory echocardiography, which could
overwhelm the clinical workforce. The Ministry
of Health had indicated that the most feasible
and sustainable means of undertaking a dedicated
rheumatic heart disease screening programme would
be to train nurses working with school health teams
to undertake basic rheumatic heart disease echo-
cardiography screening. School health nurses are
employed by the Fiji Ministry of Health and are
located in all regions of Fiji.
Secondary prevention, delivery of three to four
weekly penicillin injections to patients with a
history of acute rheumatic fever or rheumatic heart
disease, is a cost-effective method of disease preven-
tion and control.8 A coordinated national rheumatic
heart disease control and secondary prevention
programme has been running in Fiji since 2005.
Regular administration of penicillin injections to
children with mild heart valve lesions can result
in up to 70% having no detectable disease 5 to
10 years later.9–13 In the absence of a screening
programme, most patients with rheumatic heart
disease are identified because they become sympto-
matic with cardiac failure, reflecting progression to
severe valvular disease.
Materials and methods
This pilot study had three main components: the
first step was a training workshop for nurses in basic
rheumatic heart disease echocardiography. In the
second step, the nurses completed 2 weeks of
supervised field screening training. The third step
was a blinded comparison of the nurses’ ability to
identify patients with rheumatic heart disease on
echocardiography compared with a paediatric
cardiologist also using echocardiography (Fig 1).
Two nurses were selected to participate in the
pilot study. Both nurses had over 10 years of clinical
experience, as well as research and public health
experience in the field of rheumatic heart disease;
however, neither nurse had any prior knowledge or
Figure 1.
Flowchart showing analysis of the study design. RHD5 rheumatic
heart disease.
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experience in echocardiography. Informed consent
was obtained from all participating children before
any study procedures; assent was obtained from all
children over 10 years of age. Ethics approval to
undertake this project was obtained from the
Fiji National Research Ethics Committee, the
Human Research Ethics Committee of the Northern
Territory Department of Health, and the Menzies
School of Health Research. Approval was also
obtained from the Fiji Ministry of Education and
selected participating primary schools.
Workshop and field training/experience phase
A week-long rheumatic heart disease echocardio-
graphy training workshop was held in March, 2010.
The training was facilitated by two paediatricians
with extensive experience in rheumatic heart disease
echocardiography. The nurses received training in
basic rheumatic heart disease echocardiography, with
an emphasis on obtaining views of the left side of the
heart and identifying mitral valve regurgitation, and
capturing images of the mitral and aortic valve in
three views – Parasternal Long-Axis, Parasternal
Short-Axis, and Apical. The primary emphasis was
on identifying and measuring a regurgitant mitral
and/or aortic jet using colour Doppler function.
Nurses were also asked to comment on whether the
mitral and aortic valves appeared normal or abnormal.
The nurses were trained to follow a basic 11-step
rheumatic heart disease screening echocardiography
algorithm (Table 1).
Following the workshop, the nurses completed
2 weeks of echocardiography screening in two primary
schools supervised by experienced doctors and echo
technicians. It was intended that each nurse would
undertake 60–80 echocardiograms, over this 2-week
period, with a focus on gaining dexterity, experience,
and competency in identifying children who require
cardiac referral before the testing of their skills. If the
supervising staff felt that the echocardiogram identi-
fied children with possible acute rheumatic carditis,
rheumatic heart disease, or other abnormal cardiac
findings, they were referred for further off-study
clinical investigation to the Paediatrics Department at
Fiji’s tertiary hospital, the Colonial War Memorial
Hospital, Suva.
Testing phase
In the week following the field experience, the
nurses’ skills were tested on a blinded sample of
50 children. Children who had been screened using
echocardiography in 2008, whose cardiac diagnosis
was known, were approached to participate in
this phase of the study. The 50 selected children
included 10 children with rheumatic heart disease
and 40 with normal echocardiographic findings as
diagnosed in 2008. The 50 children involved in this
phase each had three echocardiograms undertaken
on the same day, one by each of the nurses being
tested and the third by the cardiologist – all
examiners were blinded to each other’s findings.
Referral thresholds for nurses
We chose conservative measurements for the nurses
to determine the need for referral – 1 cm of mitral
regurgitation and/or the presence of any aortic
regurgitation – to limit the likelihood of false
negatives.
Case definitions for rheumatic heart disease for the
gold standard reader
The definitions for definite and probable rheumatic
heart disease used in this study were those used in
previous screening studies in Fiji (Table 2). The
cardiologist acting as the ‘‘gold standard’’ echocardio-
grapher was asked to follow these guidelines when
categorising rheumatic heart disease cases detected
among the 50 children in the testing sample.14
Table 1. Eleven-step basic algorithm for nurse-led RHD screening echocardiography.
Step View Mode
1 Parasternal Long-Axis 2-D
2 Parasternal Long-Axis Colour Doppler mitral valve
3 Parasternal Long-Axis Colour Doppler aortic valve
4 Parasternal Short-Axis at the level of the aortic valve 2-D
5 Parasternal Short-Axis at the level of aortic valve Colour Doppler
6 Parasternal Short-Axis at the level of mitral valve 2-D
7 Parasternal Short-Axis at the level of the mitral valve Colour Doppler
8 Apical four-chamber 2-D (also visualise the mitral valve)
9 Apical four-chamber Colour Doppler of the mitral valve
10 Apical four-chamber 2-D (visualise the aortic valve well)
11 Apical four-chamber Colour Doppler of aortic valve
2-D5 two-dimensional; RHD5 rheumatic heart disease
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All echocardiography examinations were performed
using portable Mindray machines (Mindray Diagnos-
tic Ultrasound System Model M5, Mahwah, New
Jersey, United States of America). These relatively
inexpensive machines allow two-dimensional, motion-
mode, colour Doppler mapping, and continuous wave
and pulse wave Doppler imaging. All echocardio-
graphy was undertaken in a transthoracic mode using
an appropriate ultrasound gel and with the aid of
electrocardiography tracing.
Data analysis
The nurses were asked to obtain and record measure-
ments of mitral valve regurgitation and comment on
the presence of any aortic valve regurgitation. The
nurses’ measurements of regurgitant mitral valve jet
length in the Parasternal Long-Axis and Apical views
were categorised into three divisions: jet of Z2 cm,
Z1.5 cm, or Z1 cm. Assessment of aortic valve
regurgitation was a simple ‘‘yes/no’’ assessment. The
nurses also commented on the presence or absence of
mitral valve morphology. The primary outcome
measure was the nurses’ finding of a mitral regurgitant
jet and/or any aortic regurgitation – so-called ‘‘screen-
positive’’ – compared with the cardiologist assessment
of definite rheumatic heart disease as defined by the
study criteria, for each nurse. Sensitivity and
specificity with 95% confidence intervals were
calculated for all comparisons. In addition, other
comparisons were made between the nurses’ and
cardiologist’s assessment of mitral valve jet length
using Spearman’s correlation coefficient.
Results
Of the 10 patients who were classified as having
definite rheumatic heart disease in 2008, only six met
the criteria for definite rheumatic heart disease in
2010 as per the echocardiogram performed by the
study cardiologist (Table 3); three children no longer
met the criteria for definite rheumatic heart disease
despite having some abnormalities of the mitral valve.
These features included either significant regurgita-
tion in at least one view or significantly abnormal
valve morphology. There was one patient who had a
congenital abnormality of the aortic valve – bicuspid
aortic valve – that was not previously detected. All
three nurses correctly identified this case as having
an abnormal aortic valve. This case was excluded
from the analysis. No children with a previously
normal echocardiogram developed definite or prob-
able rheumatic heart disease during the 2-year period.
Therefore, the case mix for the nurses consisted of
six rheumatic heart disease cases out of 49.
A total of seven children were found by the cardio-
logist to have a regurgitant mitral valve jet of between
Table 2. Definition of RHD on echocardiogram (modified from the World Health Organization and the National Institutes of Health
RHD working party guidelines).14
Definite RHD
Definite mitral regurgitation due to RHD Significant mitral regurgitation on echocardiographya plus morphological
changes of the mitral valve on echocardiographyb
Definite aortic regurgitation due to RHD Significant aortic regurgitation on echocardiographyc plus morphological
changes of the mitral valve on echocardiography without another evident
aetiology for aortic insufficiency, such as bicuspid valve or annuloaortic ectasia
Definite mitral stenosis due to RHD Significant mitral stenosis on echocardiography.d
Additional echocardiographic changes that may be present include thickening
of the mitral valve leaflets, ‘‘elbow’’ or ‘‘dog-leg’’ deformity of the anterior
mitral valve leaflet, fixed or markedly restricted motion of the posterior mitral
leaflet, calcification, and commissural thickening
Probable RHD
Probable mitral regurgitation due to RHD Significant mitral regurgitation on echocardiography without morphological
changes of the mitral valve on echocardiography
Probable aortic regurgitation due to RHD Significant aortic regurgitation on echocardiography without morphological
changes of the mitral valve
Probable mitral valvular pathology due to RHD Morphological changes of the mitral valve on echocardiography without
significant mitral stenosis, mitral regurgitation, or aortic regurgitation
RHD5 rheumatic heart disease
aSignificant mitral regurgitation on echocardiography is defined as: a mitral regurgitant jet at least 2 cm from the coaptation point of the valve
leaflets, seen in two planes, with a high-velocity mosaic pattern and persisting throughout systole
bMorphological changes of the mitral valve on echocardiography are defined as: thickened mitral valve leaflets and/or elbow or dog-leg deformity
of the anterior mitral valve leaflet
cSignificant aortic regurgitation on echocardiography is defined as: an aortic regurgitant jet at least 1 cm from the coaptation point of the valve
leaflets, with a high-velocity mosaic pattern and seen in two planes
dSignificant mitral stenosis on echocardiography is defined as: evidence of flow acceleration across the mitral valve with a mean pressure gradient
.4mmHg
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1.5 and 1.99 cm and eight children had a regurgitant
mitral valve jet of between 1.0 and 1.49 cm. The
remaining 27 children had either no mitral regurgita-
tion or regurgitation measuring ,1 cm. Of the 49
included children, three were found to have an aortic
valve jet .1 cm and the remaining 46 children had
,0.99 cm or no aortic valve regurgitation.
Data comparing Nurse A and B’s screen positive
cases at varying lengths of mitral regurgitation
against the gold standard diagnosis of rheumatic
heart disease are presented in Table 4. Of the six
children identified by the cardiologist as having
definite rheumatic heart disease, Nurse A identified
three of these cases on the basis of mitral
regurgitationZ1.5 cm, whereas Nurse B identified
four. The remaining cases were identified on the
basis of aortic regurgitation. Indeed, of the total
sample the nurses identified 13 and 8 cases with
some evidence of aortic regurgitation. This was at
odds with the cardiologist who found only three
children with aortic regurgitation as outlined above.
The nurses were not required to measure the length
of the aortic regurgitant jets, thereby not allowing
any further detailed analysis; however, it is likely
that the majority of these children were identified as
having ,1 cm. When we compared the nurses’
measurement of the length of the mitral regurgitant
jet directly against the cardiologist’s measurement,
there was only fair agreement with a Spearman’s
correlation coefficient of 0.46 and 0.39 for Nurse A
and B, respectively (Fig 2).
The aim of this pilot project training was to focus
on the nurse’s ability to detect mitral and/or aortic
regurgitation and identify cases that require referral
with high sensitivity and specificity. They were,
however, asked to answer a yes or no question, given
their very brief level of training, on whether they
thought abnormal mitral valve morphology was
present. The cardiologist identified a total of 17 out
of 50 cases with some degree or abnormal or
suspicious mitral valve morphology. Of these, two
cases also had an aortic valve abnormality recorded;
it is noteworthy that there were no cases identified
with isolated aortic valve abnormality.
Discussion
This pilot project has demonstrated that nurses, given
brief focused training and supervised field experience,
can follow an algorithm to undertake rheumatic heart
Table 3. Characteristics of the six patients who were identified by the cardiologist as having definite RHD.
Mitral valve Aortic valve
Case Morphology
MR PLAX
(cm)
MR apical
(cm) Morphology
AR PLAX
(cm)
AR apical
(cm)
1 Elbow deformity, thickened AMVL 2.4 3 Thickened and rolled leaflets 1.8 1.0
2 Thickened AMVL 2.6 3.4 Normal Nil Nil
3 Elongated chordae, thickened
AMVL, tethered PMVL
2.5 2.8 Normal Nil Nil
4 Thickened AMVL 2.2 2.1 Normal Nil Nil
5 Thickened AMVL 2.2 Nil Normal 1.4 Nil
6 Thickened AMVL Nil Nil Thickened leaflets 1.0 1.5
AMVL5 anterior mitral valve leaflet; AR5 aortic regurgitation; MR5mitral regurgitation; PLAX5 Parasternal Long-Axis; PMVL5 posterior
mitral valve leaflet; RHD5 rheumatic heart disease
Table 4. Sensitivity and specificity of nurses in identifying cases of definite RHD as defined by study definitions (n5 6), when nurses
used different mitral regurgitation jet length cut-offs and presence of any aortic regurgitation as screen positivea.
Cut-off used for mitral
regurgitant jet
Number of cases
detected by nurse Sensitivity 95% CI Specificity 95% CI
Nurse A Z1 cm 31 100 54.1–100 41.9 27–57.9
Z1.5 cm 20 100 54.1–100 67.4 51.5–80.9
Z2 cm 15 66.7 22.3–95.7 74.4 58.8–86.5
Nurse B Z1 cm 16 100 54.1–100 76.7 61.4–88.2
Z1.5 cm 14 83 35.9–99.6 79.1 64–90
Z2 cm 8 83 35.9–99.6 93 80.9–98.5
RHD5 rheumatic heart disease
aNurses were not asked specifically to identify cases of RHD, but to identify cases with significant mitral regurgitation using different cut-offs
and presence of aortic regurgitation, to be referred for further assessment
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disease echocardiography in a developing country
setting with reasonable accuracy.
The current guidelines for rheumatic heart disease
describe significant mitral regurgitation as being
a mitral regurgitant jet of at least 2 cm from the
coaptation point of the valve leaflets with a pansystolic
signal on colour Doppler and peak velocity .3m/s.14
Comparing the nurses’ results for mitral regurgitation
at the cut-off level of 1.5 cm with the cardiologist’s
detection of rheumatic heart disease showed good
sensitivity and specificity (Table 4). Using a 1-cm
cut-off for mitral valve regurgitation resulted in
excellent sensitivity results but poor specificity,
suggesting that a 1.5-cm cut-off may be a more
appropriate level to focus on in the next proposed
phase of this project, assuming that mitral valve
regurgitation ,1.5 cm continues to be considered
irrelevant in diagnostic guidelines developed in future.
The finding that the exact measures of mitral
regurgitant jets by nurses were not as reliable suggests
that the focus should be more on asking nurse
screening echocardiographers to detect children for
further referral, as we set out to do in this study, rather
than to try to have them make more advanced
judgements based on specific measurements such
as exact jet length and subtle changes in valve
morphology. Identifying just mitral regurgitation
alone did not pick up all the cases: three out of
six for Nurse A and four out of six for Nurse B. It is
important that we keep aortic regurgitation in our
future ‘‘screen positive’’ definition because: first, the
nurses’ finding of aortic regurgitation – any jet
identified – increased sensitivity; second, one of the
definite rheumatic heart disease cases had aortic
regurgitation alone and would have been missed if
we did not include aortic regurgitation in the ‘‘screen
positive’’. These results warrant further research, with
a view to developing a module to guide rheumatic
heart disease echocardiographic screening by nurses
within the existing public health infrastructure in
high-prevalence, resource-poor regions. A key factor in
determining an appropriate screening module is the
accuracy of the screening tool to correctly identify
children who require further clinical referral without
missing cases, that is, ensure high sensitivity, and the
ability of the tool to exclude large numbers of children
whose cardiac pathology is normal – high specificity.
Poor sensitivity leads to potentially missed rheumatic
heart disease cases that may go on to present with
severe untreatable disease, yet unnecessary referral of a
large number of cases for clinical review could
overwhelm already burdened clinical services.
This pilot study has shown that when given
brief comprehensive training nurses can operate
sophisticated portable echocardiography machines
with competence and detect findings suggestive of
rheumatic heart disease with high sensitivity and
reasonable specificity. Additional training and
experience will be required to increase specificity.
It was our anecdotal experience in this study that
the nurses were able to acquire reasonable images in
the four views by the end of the first week of
training, although optimisation of these images
required considerably more time. Further develop-
ment of a rheumatic heart disease training module
for nurses in a high-prevalence, resource-poor
setting might include a longer period of supervised
field experience and be undertaken utilising
standardised rheumatic heart disease echocardiogra-
phy guidelines and protocols when they become
available.15
There are a number of limitations to our study,
largely due to the pilot nature of the study. Only
two nurses were tested, and thus generalisability of
the results is limited. Practical aspects of the study
relevant to implementation in the field were not
measured, including the time spent per evaluation
by the nurse. Only regurgitant jets were evaluated
by the nurses without evaluation of changes in valve
morphology on two-dimensional imaging.
There are currently no published studies that
examine the cost-effectiveness of rheumatic heart
disease echocardiography screening in resource-poor
settings. Although there is good reason to think
that early detection of rheumatic heart disease will
3.5
95% CI
Fitted values
Cardiologist
3(a)
(b)
Nurse A
95% CI
Fitted values
Cardiologist
2.5
2
1.5
1
1 1.5 2 2.5
Nurse B
1 1.5 2 2.5
3
2.5
2
1.5
1
Figure 2.
Correlation of Nurse A and B’s measurement of mitral
regurgitation jet length to that of the cardiologist.
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lead to reduced health-care costs and increased
lifetime productivity in individual patients, this
has not been formally assessed. Although port-
able echocardiography machines are becoming more
affordable, undertaking disease screening at a public
health level is labour intensive and may have
considerable downstream workforce consequences.
A cost-effectiveness study of rheumatic heart disease
screening is planned in Fiji.
In 2011, the World Heart Federation developed
an evidence-based guideline for echocardiographic
diagnosis of rheumatic heart disease.15 Our current
study provides a useful basis for the next phase of
development of the training module, which will
utilise these new standardised echocardiographic
criteria. In 2012, we aim to train an additional seven
nurses, with the aim of validating the rheumatic heart
disease echocardiography screening module and
increasing the Ministry of Health rheumatic heart
disease screening capacity across the country, potenti-
ally providing an echocardiography training model to
be utilised in the future in Fiji and elsewhere in the
Pacific region. With the newly developed inter-
national rheumatic heart disease echocardiography
consensus guidelines, the pilot data from this current
study and further data from our planned larger nurse-
led echocardiography study, investigators and public
health leaders will be in a better position to define
feasible methodology for rheumatic heart disease
screening in resource-poor settings.
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